Key result
Inhibiting GSNOR or supplementing with CysNO increased intracellular RSNO and enhanced myoblast proliferation while decreasing fusion, independently of cGMP signaling.
Population
Primary cultures of chick embryonic skeletal muscle cells
Comparison
S-nitrosocysteine, 8-Br-cGMP, DETA-NO, or… vs Control cultures without the specific…
Design
Preclinical
Follow-up
72 h
Authors
Loading...
Cautions against clinical use of GSNOR inhibition; leaves open its role in cardiac muscle regeneration.
Myoblast proliferation is enhanced by increasing RSNO and regulated by GSNOR activity independently of cGMP production and signaling.
Yamashita et al. (2017) studied Myogenesis. GSNOR inhibition (GSNORi or siRNA) and CysNO supplementation vs. Control (absence of inhibitors/supplementation) was evaluated on Myoblast proliferation and fusion index. Inhibiting GSNOR or supplementing with CysNO increased intracellular RSNO and enhanced myoblast proliferation while decreasing fusion, independently of cGMP signaling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: